Home/Hedge Fund Intelligence/Ocular Therapeutix, Inc
Nasdaq: OCULStockForm 13F30 Jun 2026

Hedge funds that hold Ocular Therapeutix, Inc Nasdaq: OCUL

CUSIP 67576A100 · who reports it, how much, and how much it matters to them

36 of the 720 hedge fund managers we track reported shares of Ocular Therapeutix, Inc (Nasdaq: OCUL) on Form 13F for 30 June 2026. Between them they reported USD 544m. The largest position belongs to Deep Track Capital, at USD 193m. The manager with the most riding on it is Acuta Capital Partners, where it is 3.6% of the reported book.

Managers reporting it36of 720 we track
Value they reportUSD 544mshares only, 30 Jun 2026
Funds they run421with a file on PPLI.com
Largest positionUSD 193mDeep Track Capital
Typical weight0.0%median share of a manager's book
Heaviest weight3.6%Acuta Capital Partners

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

36 managers, USD 544m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Ocular Therapeutix, Inc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Deep Track Capital1 fund on PPLI.comUSD 193m2.8%
2Avoro Capital Advisors1 fund on PPLI.comUSD 123m1.1%
3Logos Global Management1 fund on PPLI.comUSD 52m2.2%
4POINT72 Asset Management17 funds on PPLI.comUSD 32m0.0%
5Balyasny Asset Management25 funds on PPLI.comUSD 22m0.0%
6Octagon Capital Advisors1 fund on PPLI.comUSD 20m1.8%
7Adage Capital Management1 fund on PPLI.comUSD 15m0.0%
8Squarepoint Ops7 funds on PPLI.comUSD 14m0.0%
9Boxer Capital Management1 fund on PPLI.comUSD 13m1.0%
10Two Sigma Investments35 funds on PPLI.comUSD 12m0.0%
11Sio Capital Management4 funds on PPLI.comUSD 5.3m0.9%
12Acuta Capital Partners2 funds on PPLI.comUSD 5.2m3.6%
13Tudor Investment Corporation10 funds on PPLI.comUSD 5.1m0.0%
14HighVista Strategies27 funds on PPLI.comUSD 4m0.9%
15Rock Springs Capital Management2 funds on PPLI.comUSD 3.8m0.2%
16Renaissance Technologies13 funds on PPLI.comUSD 3.7m0.0%
17Citadel Advisors32 funds on PPLI.comUSD 3m0.0%
18Verition Fund Management3 funds on PPLI.comUSD 2.9m0.0%
19Orbimed Advisors1 fund on PPLI.comUSD 2.2m0.0%
20Walleye Capital8 funds on PPLI.comUSD 2m0.0%
21Boothbay Fund Management2 funds on PPLI.comUSD 1.8m0.0%
22Exome Asset Management2 funds on PPLI.comUSD 1.8m1.1%
23Marshall Wace LLP84 funds on PPLI.comUSD 1.2m0.0%
24D. E. Shaw & Co.15 funds on PPLI.comUSD 1.2m0.0%
25J. Goldman & Co.1 fund on PPLI.comUSD 999,0000.0%
26Exoduspoint Capital Management7 funds on PPLI.comUSD 508,0000.0%
27Mirabella Financial Services LLP10 funds on PPLI.comUSD 438,0000.0%
28Engineers Gate Manager1 fund on PPLI.comUSD 401,0000.0%
29Campbell & Company Investment Adviser8 funds on PPLI.comUSD 306,0000.0%
30Brevan Howard Capital Management39 funds on PPLI.comUSD 242,0000.0%
31Jain Global1 fund on PPLI.comUSD 225,0000.0%
32Prelude Capital Management9 funds on PPLI.comUSD 190,0000.0%
33Entrypoint Capital1 fund on PPLI.comUSD 137,0000.0%
34Schonfeld Strategic Advisors30 funds on PPLI.comUSD 105,0000.0%
35Graham Capital Management18 funds on PPLI.comUSD 104,0000.0%
36The Quarry1 fund on PPLI.comUSD 31,7970.0%
Next: where it matters most
Where it matters most

For Acuta Capital Partners it is 3.6% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Acuta Capital PartnersUSD 5.2m3.6%
2Deep Track CapitalUSD 193m2.8%
3Logos Global ManagementUSD 52m2.2%
4Octagon Capital AdvisorsUSD 20m1.8%
5Avoro Capital AdvisorsUSD 123m1.1%
6Exome Asset ManagementUSD 1.8m1.1%
7Boxer Capital ManagementUSD 13m1.0%
8HighVista StrategiesUSD 4m0.9%
9Sio Capital ManagementUSD 5.3m0.9%
10Rock Springs Capital ManagementUSD 3.8m0.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Ocular Therapeutix, Inc

What is the ticker symbol of Ocular Therapeutix, Inc?

Ocular Therapeutix, Inc trades under the symbol OCUL on the Nasdaq. Its CUSIP, the code used on Form 13F, is 67576A100.

Which hedge funds own Ocular Therapeutix, Inc (Nasdaq: OCUL)?

36 of the 720 hedge fund managers PPLI.com tracks reported Ocular Therapeutix, Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Deep Track Capital (USD 193m), Avoro Capital Advisors (USD 123m), Logos Global Management (USD 52m), POINT72 Asset Management (USD 32m) and Balyasny Asset Management (USD 22m).

How many hedge funds hold Ocular Therapeutix, Inc?

36 managers in our coverage reported it, and between them they run 421 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Ocular Therapeutix, Inc?

Acuta Capital Partners, where the position was 3.6% of the reported 13F book at 30 June 2026.

Does this show who is short Ocular Therapeutix, Inc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Ocular Therapeutix, Inc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.